You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Pediatric Neurology
 •Neurology, Other
 •Oncology
 •Brain Cancer
 •Pediatrics
 •Pediatrics, Other
 •Diagnosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Occurrence of Basal Ganglia Germ Cell Tumors Without a Mass

Salah Almubarak, MD; Yee-Chiung Gan, FRCS; Paul Steinbok, MBBS, FRCSC; Glenda Hendson, MBBCh, FRCPC; Ken Poskitt, MDCM, FRCPC; Helen Nadel, MD, FRCPC; Karen Goddard, FRCPC, FRCP(UK); Juliette Hukin, MBBS, FRCPC

Arch Neurol. 2009;66(6):789-792.

Objective  To report a case series in which basal ganglia calcifications without mass effect proved to be germ cell tumors.

Design  Case series.

Setting  Tertiary care hospital.

Patients  Four patients.

Interventions  Computed tomography, magnetic resonance imaging, positron emission tomography, biopsy, chemotherapy, and radiation therapy.

Main Outcome Measures  Recognition of clinical syndrome and radiological features.

Results  All patients had progressive hemiparesis, and 1 patient also had frontal lobe dementia. Imaging demonstrated progressive asymmetric signal abnormality with basal ganglia calcification and associated brainstem atrophy. Fludeoxyglucose F 18–positron emission tomography showed hypometabolism in contrast to malignant glioma.

Conclusion  Germ cell tumor should be considered in patients with an indolently progressive neurological course, particularly if basal ganglia calcification is present with or without enhancement, asymmetric brain atrophy, or a mass.


Author Affiliations: Divisions of Neurology (Drs Almubarak and Hukin), Neurosurgery (Drs Gan and Steinbok), Neuropathology (Dr Hendson), Neuroradiology (Dr Poskitt), Nuclear Medicine (Dr Nadel), and Oncology (Drs Goddard and Hukin), BC Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.